CW 8-K Filed 2026-08-19 Amendment

Curtiss-Wright expands 2026 share repurchase program by $100M

Company increases annual buyback guidance to $260M through new 10b5-1 plan and existing $60M program.

Remaining$290M
Mechanism10b5-1 plan

What the filing says

Curtiss-Wright Corporation announced a $100 million expansion of its 2026 share repurchase program on August 18, 2026. The new authorization brings the company's total expected annual share repurchases to $260 million for 2026, combining the new $100 million expansion with the existing $60 million share repurchase program initiated in January 2026.

The $100 million expansion will be executed immediately via a 10b5-1 trading plan. The existing $60 million program is expected to be completed during 2026. Upon completion of both programs, Curtiss-Wright will have $290 million remaining under its open repurchase authorization.

Chair and CEO Lynn M. Bamford stated that the expansion "underscores our disciplined approach to long-term value creation for our shareholders" and reflects the Board's confidence in the company's Pivot to Growth strategy, balance sheet strength, and long-term financial outlook.

Curtiss-Wright Corporation (NYSE: CW) today announced a $100 million expansion of its 2026 share repurchase program, which is now expected to yield annual share repurchases of $260 million in 2026. — CURTISS WRIGHT CORP 8-K filing  ·  View on SEC EDGAR →

What this means

Curtiss-Wright's $100 million program expansion increases its total 2026 buyback commitment to $260 million, composed of the new $100 million 10b5-1 plan and the previously announced $60 million program. The company retains $290 million in open authorization for future repurchases. This signals management confidence in cash generation and valuation, though the impact on share count depends on execution prices and timing. The use of a 10b5-1 plan provides automatic execution under pre-set parameters, reducing discretion and timing risk.

Frequently asked questions

What is a 10b5-1 trading plan?
A 10b5-1 plan is an SEC-compliant mechanism that allows a company to repurchase shares automatically according to pre-set parameters (price, volume, timing) established in advance. Once adopted, the plan executes without further board intervention, reducing market-timing concerns and insider-trading risk. Curtiss-Wright will use this plan to execute the new $100 million expansion immediately.
Why is Curtiss-Wright expanding its buyback program?
According to CEO Lynn Bamford, the expansion reflects the Board's confidence in the company's Pivot to Growth strategy, healthy balance sheet, and long-term financial outlook. The company views this as part of its disciplined approach to long-term shareholder value creation, not necessarily a response to undervaluation.
What happens when the existing programs are completed?
Once both the new $100 million and existing $60 million programs are completed in 2026, Curtiss-Wright will have $290 million remaining under its open repurchase authorization. This remaining authorization provides flexibility for future repurchases without requiring board approval for each tranche.
How much total buyback authorization does Curtiss-Wright now have?
Upon completion of the $260 million in 2026 programs ($100M new plus $60M existing), the company will have $290 million remaining, for a total of $550 million in authorized repurchases ($260M + $290M remaining).
What is Curtiss-Wright's Pivot to Growth strategy?
The filing does not provide detailed specifics on the Pivot to Growth strategy, but CEO Bamford cites it as a basis for the Board's confidence in future cash flow and financial outlook. The filing indicates Curtiss-Wright serves Aerospace & Defense, Commercial Nuclear Power, and Process and Industrial markets with approximately 9,200 employees.
authorization amendment 10b5-1 plan aerospace-defense mid-cap
Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.